Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
British Medical Journal (Clinical Research Ed.)|January 10, 1981
Problems of the oncology outpatient: role of the liaison health visitorJ M Trotter, R Scott, F R Macbeth, et al.Hematological Oncology|April 1, 1984
A report on a prospective trial of no initial therapy in patients with initial therapy in patients with asymptomatic favourable prognosis non-Hodgkin's lymphomaG M Mead, F R Macbeth, R D Ryall, et al.FEBS Letters|May 16, 2017
Crystal structure of the Entamoeba histolytica RNA lariat debranching enzyme EhDbr1 reveals a catalytic Zn2+ /Mn2+ heterobinucleationElizabeth Ransey, Eduardo Paredes, Sourav K Dey, et al.The Journal of Biological Chemistry|April 26, 2011
Structure of the membrane-tethering GRASP domain reveals a unique PDZ ligand interaction that mediates Golgi biogenesisSteven T Truschel, Debrup Sengupta, Adam Foote, et al.British Journal of Cancer|August 1, 1984
Second look laparotomy in the management of epithelial cell carcinoma of the ovaryG M Mead, C J Williams, F R MacBeth, et al.BMC Cancer|October 8, 2009
FRAGMATIC: a randomised phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancerGareth O Griffiths, Sarah Burns, Simon I Noble, et al.British Journal of Cancer|January 1, 1981
Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stabilityR E Leake, L Laing, K C Calman, et al.Journal of the American Chemical Society|September 10, 2004
A transition state analogue for an RNA-editing reactionBrittany L Haudenschild, Olena Maydanovych, Eduardo A Véliz, et al.Science (New York, N.Y.)|September 6, 2005
Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editingMark R Macbeth, Heidi L Schubert, Andrew P Vandemark, et al.Cancer Treatment Reports|September 1, 1982
Epileptic seizures associated with cisplatin administrationG M Mead, A M Arnold, J A Green, et al.Pageof 4